SCHEMBL1661901

SCHEMBL1661901

O=[C]c1coc(Oc2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.43
F2 P00734 1/20 0.42
GRM5 P41594 1/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.40
MGLL Q99685 1/20 0.40
ABHD6 Q9BV23 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39
F10 P00742 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
LTA4H P09960 1/20 0.38
PTGS2 P35354 1/20 0.38
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1659045 0.79 GRM5 (0.30) GRM5
SCHEMBL12521291 0.79 F2 (0.47) ABCG2F2ALDH1A1MGLLABHD6
SCHEMBL1660451 0.74 HTR2C (0.36)
SCHEMBL4203388 0.73 TSHR (0.67) ABCG2F2ALDH1A1LMNATSHR
SCHEMBL6273333 0.72 TSHR (0.64) ABCG2F2ALDH1A1LMNATSHR
SCHEMBL30043252 0.72 TSHR (0.64) ABCG2F2ALDH1A1LMNATSHR
SCHEMBL10352832 0.71 ABCG2 (0.56) ABCG2ALDH1A1LMNATSHRLPAR3
SCHEMBL9158141 0.70 ALDH1A1 (0.67) ALDH1A1LMNATSHRCYP2C9CYP2C19
SCHEMBL9356592 0.70 ALDH1A1 (0.67) ALDH1A1LMNATSHRCYP2C9CYP2C19
SCHEMBL4456862 0.69 ALDH1A1 (0.60) ABCG2ALDH1A1LMNATSHRLPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed